Research progress on postoperative delirium in pseudomyxoma peritonei

Area of Science:

• Oncology
• Geriatrics
• Surgical Complications

Background:

• Pseudomyxoma Peritonei (PMP) is a rare malignancy primarily treated with cytoreductive surgery (CRS).
• Postoperative delirium (POD) is a significant complication in PMP patients, linked to adverse prognoses.
• Limited research exists on POD specifically within the PMP patient population.

Purpose of the Study:

• To comprehensively review the definition, pathogenesis, assessment, risk factors, and management strategies for POD.
• To highlight the unique considerations of POD in the context of PMP.
• To emphasize the importance of early recognition and optimized management of POD in PMP patients.

Main Methods:

• Literature review focusing on Pseudomyxoma Peritonei and Postoperative Delirium.
• Synthesis of information regarding POD definition, etiology, and clinical presentation.
• Analysis of risk factors, diagnostic tools, and therapeutic interventions for POD.

Main Results:

• POD presents unique challenges in PMP patients due to tumor characteristics and treatment intensity.
• Key risk factors and assessment methods for POD are identified.
• Preventive and therapeutic strategies are discussed in relation to PMP management.

Conclusions:

• Optimized management of POD in PMP patients is crucial for reducing incidence and improving patient outcomes.
• Early detection and intervention for POD can significantly enhance quality of life for PMP survivors.
• Further research is warranted to fully elucidate POD's impact on PMP.